{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:00:30Z","timestamp":1788908430495,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","e-jmii.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jmii.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T10:33:33Z","timestamp":1420886013000},"page":"969-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)"],"prefix":"10.1016","volume":"49","author":[{"given":"Shio-Shin","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Woon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Wang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray-Jade","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Jong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jien-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(08)70002-5","article-title":"Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus","volume":"31","author":"Gould","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2334-10-159","article-title":"Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC\u00a0=\u00a02\u00a0mg\/L, by the broth microdilution method","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2014.12.008_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/AAC.01009-08","article-title":"Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in\u00a0vitro pharmacodynamic model","volume":"53","author":"Rose","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib4","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2014.12.008_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jac\/dkm492","article-title":"In\u00a0vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin","volume":"61","author":"Pillar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib7","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.01181-06","article-title":"Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib8","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/AAC.00060-10","article-title":"Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole","volume":"54","author":"Queenan","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijantimicag.2012.02.016","article-title":"Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone","volume":"39","author":"Davies","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijantimicag.2010.07.016","article-title":"In\u00a0vitro activity of ceftobiprole against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA)","volume":"36","author":"Saravolatz","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib11","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement M100\u2013S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.jmii.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jmii.2013.07.002","volume":"48","author":"Jean","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2014.12.008_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","article-title":"Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes","volume":"38","author":"Tzelepi","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/45.6.881","article-title":"Detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL","volume":"45","author":"M'Zali","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib15","first-page":"36","article-title":"Evaluation of the in\u00a0vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey","volume":"22","author":"Ece","year":"2014","journal-title":"Infez Med"},{"key":"10.1016\/j.jmii.2014.12.008_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011)","volume":"78","author":"Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.12.008_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3855\/jidc.2851","article-title":"Infection due to colistin-resistant Enterobacteriacae in critically-ill patients","volume":"7","author":"Garbati","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jmii.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00128071-200809040-00004","article-title":"Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin","volume":"9","author":"Zhanel","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jmii.2014.12.008_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/dkq397","article-title":"Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study","volume":"66","author":"Rossolini","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.diagmicrobio.2008.02.008","article-title":"Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005\u20132006)","volume":"61","author":"Fritsche","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/AAC.01351-07","article-title":"Antimicrobial activity of ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)","volume":"52","author":"Sader","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2010.11.035","article-title":"In\u00a0vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints","volume":"37","author":"Lascols","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2013.02.001","volume":"41","author":"Jean","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib24","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1128\/AAC.00878-12","article-title":"Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011","volume":"56","author":"Lee","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib25","doi-asserted-by":"crossref","first-page":"e69428","DOI":"10.1371\/journal.pone.0069428","article-title":"National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase","volume":"8","author":"Chiu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2014.12.008_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/JCM.00651-08","article-title":"Ertapenem resistance among extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae isolates","volume":"47","author":"Leavitt","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2014.12.008_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijantimicag.2006.11.020","article-title":"Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory","volume":"29","author":"Woodford","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2014.12.008_bib28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1128\/AAC.43.7.1669","article-title":"Roles of \u03b2-lactamases and porins in activities of carbapenems and cephalosporins against","volume":"43","author":"Mart\u00ednez-Mart\u00ednez","year":"1999","journal-title":"Klebsiella pneumoniae. Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10096-008-0610-7","article-title":"Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan","volume":"28","author":"Jean","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.12.008_bib30","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3760\/cma.j.issn.0366-6999.20131538","article-title":"Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011","volume":"127","author":"Zhang","year":"2014","journal-title":"Chin Med J"},{"key":"10.1016\/j.jmii.2014.12.008_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/jac\/28.4.612","article-title":"Imipenem resistance in Proteus mirabilis","volume":"28","author":"Mehtar","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.12.008_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.diagmicrobio.2014.07.006","article-title":"Carbapenems and piperacillin\/tazobactam for the treatment of bacteremia caused by extended-spectrum \u03b2-lactamase-producing Proteus mirabilis","volume":"80","author":"Tsai","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.12.008_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jac\/36.2.335","article-title":"Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins","volume":"36","author":"Neuwirth","year":"1995","journal-title":"J Antimicrob Chemother"}],"updated-by":[{"DOI":"10.1016\/j.jmii.2017.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T09:44:25Z","timestamp":1717667065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118215000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1684118215000213"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.12.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC","name":"copyright","label":"Copyright"}]}}